Premium
Direct access colonoscopy service for bowel cancer screening produces a positive financial benefit for patients and local health districts
Author(s) -
Clarke Louise,
Pockney Peter,
Gillies Donna,
Foster Robert,
Gani Jon
Publication year - 2019
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.14149
Subject(s) - medicine , colonoscopy , indirect costs , public health , government (linguistics) , service (business) , health care , family medicine , colorectal cancer , cancer , nursing , economic growth , business , marketing , accounting , economics , linguistics , philosophy
Background A direct access colonoscopy service (DACS) for the National Bowel Cancer Screening Program has become standard of care in Newcastle public hospitals because of the effect it has on time to colonoscopy. Cost‐effectiveness has not been studied to date. Aim The aim of this retrospective study was to analyse the cost‐effectiveness of a DACS. Methods Data were collected for patients referred to DACS between January 2014 and June 2016, and patients who were treated on the normal service pathway in 2013 prior to the introduction of the process. A cost‐benefit analysis from the patient’s and local health district’s perspective was undertaken. Results Introduction of the DACS produces a direct financial gain to patients in the form of reduced direct costs. It produces an indirect financial gain in terms of increased productivity if the patient is in work, and of increased leisure time if not in work. The DACS is modest income generating for the local health district, an evaluation which is sensitive to internal policies for distribution of government funding within a district. The DACS increases the availability of outpatient consultations to other patients, which is not a quantifiable economic benefit, but is likely to be an overall health benefit. Conclusion The introduction of DACS in the public system in Australia is of financial benefit to patients and to the local health service provider. It is likely to produce health benefits to non‐screening patients, by means of freeing consultations to be used for other indications.